Kane Biotech Secures U.S. Government Distribution Deal for Wound Care Products
Event summary
- Kane Biotech signed a distribution agreement with Marathon Medical Corporation to enter the U.S. Veterans Affairs, Department of Defense, and Indian Health Services markets.
- Marathon Medical is a federally verified Service-Disabled Veteran-Owned Small Business with extensive federal procurement contracts.
- Kane is building a contract-based sales team across the U.S. to expand its commercial network in 2026.
- The revyve Antimicrobial Wound Gel and Spray are FDA 510(k) cleared and Health Canada approved.
The big picture
Kane Biotech's strategic partnership with Marathon Medical provides a critical entry point into the U.S. government healthcare supply chain, a move that aligns with broader industry trends of leveraging federal contracts for scalable market penetration. The expansion of its sales network further strengthens its commercial infrastructure, positioning the company to compete more effectively in the advanced wound care sector.
What we're watching
- Government Market Penetration
- How Kane Biotech's partnership with Marathon Medical will affect its ability to scale within the U.S. government healthcare system.
- Sales Team Execution
- Whether Kane can effectively build and deploy its contract-based sales team to drive nationwide adoption of revyve products.
- Competitive Positioning
- The pace at which Kane can establish revyve as a leading brand in advanced wound care against existing competitors.
Related topics